Clinical Trial Update: PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy [Phase 1]

View source ↗

Summary

A Phase 1 PET imaging study using the radiotracer 64Cu-GRIP B in patients receiving CD19-directed CAR-T therapy for non-Hodgkin lymphoma is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• 64Cu-GRIP B

Snippet

Sponsor: Michael Randall | Conditions: Non Hodgkin Lymphoma | Phase 1 | Status: RECRUITING